Skip to main content
Log in

Reductase Activity of 17β-Hydroxysteroid Oxidoreductase in Prostatic Tumors of Different Histological Structure

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Reductase activity of 17β-hydroxysteroid oxidoreductase in biopsy specimens of prostatic cancer and benign hyperplasia, and prostatic intraepithelial neoplasia and serum concentrations of testosterone, 5α-dihydrotestosterone, 4-androstene-3,17-dione were compared in patients and healthy individuals. Reductase activities of 17β-hydroxysteroid oxidoreductase in soluble fraction of prostatic biopsy specimens decreased in the following order: prostatic cancer>prostatic intraepithelial neoplasia>>benign prostatic hyperplasia. No differences in serum concentrations of testosterone, 5α-dihydrotestosterone, 4-androstene-3,17-dione between these three groups of patients were found, while the mean serum concentration of these androgens in patients with prostatic tumors did not surpass the threshold normal values for men. Hence, high reductase activity of 17β-hydroxysteroid oxidoreductase can be associated with pathogenetic mechanisms of human malignant prostatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. T. Anono, Y. Kitamura, S. Fukuda, and K. Matsumoto, Steroid Biochem., 14, No.12, 1369–1377 (1981).

    Article  Google Scholar 

  2. W. Bartsch, H. Klein, U. Scheimann, et al. Ann. N. Y. Acad. Sci., 595, 53–66 (1990).

    PubMed  Google Scholar 

  3. N. Bruchovsky, Cancer Medicine, Eds. J. F. Holland et al., 4th ed., Baltimore (1997), pp. 1133–1148.

  4. K. Griffiths, M. S. Morton, and R. J. Nicholson, Eur. Urol., 32,Suppl. 3, 22–40 (1997).

    PubMed  Google Scholar 

  5. F. K. Habib, Eur. Surg. Oncol., 23, No.3, 664–668 (1997).

    Google Scholar 

  6. J. M. Hakimi, M. P. Schoenberg, R. H. Rondinelli, et al., Clin. Cancer Res., 3, No.9, 1599–1608 (1997).

    PubMed  Google Scholar 

  7. R. F. Morfin, S. Di Stefano, J. F. Charles, and H. H. Floch, J. Steroid Biochem., 13, 529–532 (1980).

    Article  PubMed  Google Scholar 

  8. P. Negri-Cesi, A. Colciago, A. Poletti, and M. Motta, Prostate, 41, No.4, 224–232 (1999).

    Article  PubMed  Google Scholar 

  9. C. M. Smith, S. A. Ballard, M. G. Wyllie, and J. R. Masters, J. Steroid Biochem. Mol. Biol., 50, Nos.3–4, 151–159 (1994).

    Article  PubMed  Google Scholar 

  10. J. D. Wilson, Endocr. Rev., 20, No.5, 726–737 (1999).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 139, No. 6, pp. 684–687, June, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Degtyar’, V.G., Babkina, T.V., Kazantseva, I.A. et al. Reductase Activity of 17β-Hydroxysteroid Oxidoreductase in Prostatic Tumors of Different Histological Structure. Bull Exp Biol Med 139, 715–717 (2005). https://doi.org/10.1007/s10517-005-0387-y

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-005-0387-y

Key Words

Navigation